Login / Signup

The benefit of statins in SARS-CoV-2 patients: further metabolic and prospective clinical studies are needed.

Maurizio BifulcoMichele CiccarelliDario BruzzeseAndrea DipasqualeAndrea G LaniaGherardo MazziottiPatrizia Gazzerro
Published in: Endocrine (2020)
Keyphrases
  • sars cov
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • cardiovascular disease
  • prognostic factors
  • peritoneal dialysis
  • respiratory syndrome coronavirus
  • coronavirus disease